Patients who fail therapy for a particularly deadly brain tumor are about to get a new option that may extend their life a few more months. The government on Wednesday approved the first new chemotherapy for brain tumors in 20 years. In a finding that should help quell Western critics, California doctors have found that the ancient healing art activates a group of nerve cells called the endorphin system to lower blood pressure and increase blood flow to the heart. Imperial College School of Medicine in London researchers have found that monthly immunotherapy for three or four years for patients weakens symptoms of the grass-pollen allergy three years after stopping the treatment. While many traditional gender roles are dissolving, the PTA is still overwhelmingly staffed and run by women.
Experts blame the disparity on a mix of economics, tradition and fear.
The contents herein are solely the opinions of Self Improvement Online editors, and should not be considered as a form of therapy nor advice. There is no guarantee of validity or accuracy. Self Improvement Online, Inc. assumes no responsibility for injury and specifically disclaims any warranty, express or implied for any products or services mentioned. If expert assistance or counseling is needed, services of a competent professional should be sought.